I just got this at the H2 group.
Phil
Yahoo! My Yahoo! Mail Make Yahoo! your home page
Welcome, pmgamer18
[Sign Out, My Account]
Mail Home - Mail Tutorials - Help
Mail | Addresses | Calendar | Notepad What's New - Mail For Mobile - Upgrades - Options Check MailCompose Search MailSearch the Web
Folders[Add - Edit]
Inbox (3) Draft Sent Bulk (3)[Empty] Trash[Empty] My Folders[Hide]
Adrenal Fatigue Dr.Mercola HCG Indolplex with DIM Monitor TRT letters dc5000 DVD
See your
credit score: $0
$200,000 Loan
Only $771/Mo.!
Find Any
Email Address
Bankrupt? You
can get a M/C
Please register your mobile phone to activate this feature.
Register your phone to receive a text message when you receive Mail from particular senders.
Previous | Next | Back to Messages Call or Instant Message
DeleteReplyForwardSpamMove...
Printable View This message is not flagged. [ Flag Message - Mark as Unread ]
To: hypogonadism2@yahoogroups.com
From: "loaded_vasdeferens" <no_reply@yahoogroups.com> Add to Address Book Add Mobile Alert
Yahoo! DomainKeys has confirmed that this message was sent by yahoogroups.com. Learn more
Date: Sat, 22 Apr 2006 01:43:00 -0000
Subject: [Hypogonadism] Issue facing Compounding Pharmacies
Firm Seeks Crackdown on Custom Made Drugs By ANDREW BRIDGES
Associated Press Writer
WASHINGTON Thousands of women who rely on custom-made hormone
drugs for relief from menopause symptoms have flooded the government
with letters opposing a drug company's effort to get health officials
to
crack down on pharmacies that sell them. The drug company Wyeth wants
the Food and Drug Administration to rein in the market for
bio-identical
hormone replacement therapy drugs. The hormones are custom mixed or
compounded by specialized pharmacies according to a doctor's
prescription.
[http://img.coxnewsweb.com/B/00/83/44/image_3344830.jpg]
<http://www.ajc.com/hp/content/shared-gen/ap/Health_Medical/Custom_Made_\
Drugs-image.html> (enlarge photo)
<http://www.ajc.com/hp/content/shared-gen/ap/Health_Medical/Custom_Made_\
Drugs-image.html> Donna Mabin, right, and cosmotologist Gladys Ayers,
left, look over a petition that they are having signed at the Park
Layne
hair salon, Monday, Feb. 27, 2006 in New Carlisle, Ohio. Thousands of
women who rely on tailor-prepared hormones for relief from the symptoms
of menopause have flooded the federal government with letters opposing
a
drug company effort to get health officials to act against the
pharmaces
that sell the prescription preparations. (AP Photo/David Kohl)
Compounding pharmacists can alter the dosages of a medicine, prepare it
in creams or liquids that are easier to take than pills or eliminate
preservatives or other secondary ingredients that might cause allergies
in a patient. Wyeth claims that some compounding pharmacies that
prepare
customized hormone preparations are duping women with products that
pose
a serious health risk. It wants federal regulators to weigh in with
seizures, injunctions and warning letters. "FDA cannot allow this
practice to continue," the Wyeth petition, signed by Washington
attorney
Andrew S. Krulwich, reads in part. FDA spokeswoman Susan Cruzan
declined
to comment, other than to say compounded hormones are not FDA-approved.
The agency recently told Wyeth it needs more than six months to review
and respond to both the petition, filed in October, and the more than
27,000 comments it has elicited. Most are either form letters or
messages submitted through the agency's Web site. "They can't take
these
away from us. Is there anything that can be done?" said Donna Mabin,
68,
a retired cashier from New Carlisle, Ohio, who was among those to
write.
"Those drug companies want to get the money out of natural hormones and
they don't care if we get sick or not." Many women turned to the
estrogen, progesterone and testosterone products sold by compounding
pharmacies after a 2002 study, part of the massive Women's Health
Initiative that tracked 161,000 women for 15 years, found replacement
hormones made by drug companies like Wyeth raised the risk of heart
attacks, breast cancer and strokes. Critics of the compounding
pharmacies want to dispel the notion that the hormone replacement
therapies such pharmacies make necessarily work better or are safer.
"They haven't been studied for safety or effectiveness and are not
produced in facilities that meet good manufacturing practices," said
Larry Sasich, a pharmacist with the Health Research Group of the
consumer watchdog Public Citizen. "We suspect a majority of patients
aren't aware of this." Medical researchers concluded in 2003 that
hormone replacement pills should be taken only as a brief treatment to
help women weather the worst symptoms of menopause. Those findings hit
Wyeth hard. Sales of the company's Prempro and Premphase, which combine
estrogen and progestin, and its Premarin, an estrogen-only pill, fell
to
$880 million in 2004 from $2.07 billion in 2001, the year before the
Women's Health Initiative released its hormone-replacement results.
Compounding pharmacists and their backers allege that Wyeth seeks to
stifle competition by calling in the FDA. "It seems to be an attempt to
use the FDA to inappropriately to eliminate competition," said L.D.
King, executive director of the International Academy of Compounding
Pharmacists, a Sugar Land, Texas, group. Wyeth counters it wants women
to realize the risks of what a spokeswoman for the Madison, N.J.-based
company characterized as a "growing, unlawful practice." "We filed our
petition so that we can ensure that women who received these
bio-identical hormones also receive truthful information about the
risks
of therapy," Wyeth spokeswoman Candace Steele said. Thousands of
American women use the compounded hormones to alleviate the hot
flashes,
flushes, sweats, sleeplessness and other hallmarks of menopause. The
hormones are derived from soy and yam but have an identical chemical
structure to the substances found in the body. The products sold by
Wyeth are based on the urine of pregnant mares. Women who use the
bio-identical hormones, along with their doctors and pharmacists, all
say the system is a throwback to when just about every medicine was
made
to fit both a doctor's order and a patient's need. "Every woman is
different. There is blood work done to ensure where their hormone level
is at, so based on those results and their symptoms, we will come up
with a formula. It's sort of old-fashioned," said Manhattan's Dr.
Jeffrey Morrison of the process he uses with patients like Lynn
Leibowitz. The doctor-pharmacist-patient "triad" involves constant
adjustments that just can't be made to the mass-produced drugs that
Leibowitz, a Manhattan psychologist and psychoanalyst, used to take,
said David Miller, the New Jersey compounding pharmacist she uses.
"We'll keep going month after month until we find the right combination
for the patients," Miller said of his work at Millers of Wyckoff, the
New Jersey pharmacy his grandfather started in 1929. As for Leibowitz,
she says the custom-compounded hormones have left her feeling better
and more in control since switching a year ago. "I love
knowing what my hormone levels are," said Leibowitz, who began taking
hormones eight years ago after she underwent a hysterectomy at 48. "I
feel much safer and it's more compatible with my body chemistry." That
sort of anecdotal evidence doesn't sway other doctors. In November, the
American College of Obstetricians and Gynecologists said there is no
scientific evidence supporting claims of increased efficacy or safety
for estrogen or progesterone regimens made by compounding pharmacies
for
women. The group said women should consider compounded hormones to have
the same or even additional safety issues as FDA-approved hormone
products. That same month, the FDA sent warning letters to 16 companies
marketing unapproved alternative hormone therapies. The FDA said the
companies were selling drugs without the agency's approval. The action
mirrored in part what Wyeth requested in its petition, but was not
linked to the filing of the document just weeks earlier, said Steele,
the company spokeswoman. And a 2004 review that appeared in Menopause,
the journal of the North American Menopause Society, found little to
recommend about compounded hormones: "In the absence of a sound
scientific basis, practitioners should not advocate the practice of
compounding (hormones) because it is not in the patient's best
interest,
it is potentially harmful and it lacks a scientific underpinning," the
review concluded.
[Non-text portions of this message have been removed]
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/hypogonadism2/
Phil
Yahoo! My Yahoo! Mail Make Yahoo! your home page
Welcome, pmgamer18
[Sign Out, My Account]
Mail Home - Mail Tutorials - Help
Mail | Addresses | Calendar | Notepad What's New - Mail For Mobile - Upgrades - Options Check MailCompose Search MailSearch the Web
Folders[Add - Edit]
Inbox (3) Draft Sent Bulk (3)[Empty] Trash[Empty] My Folders[Hide]
Adrenal Fatigue Dr.Mercola HCG Indolplex with DIM Monitor TRT letters dc5000 DVD
See your
credit score: $0
$200,000 Loan
Only $771/Mo.!
Find Any
Email Address
Bankrupt? You
can get a M/C
Please register your mobile phone to activate this feature.
Register your phone to receive a text message when you receive Mail from particular senders.
Previous | Next | Back to Messages Call or Instant Message
DeleteReplyForwardSpamMove...
Printable View This message is not flagged. [ Flag Message - Mark as Unread ]
To: hypogonadism2@yahoogroups.com
From: "loaded_vasdeferens" <no_reply@yahoogroups.com> Add to Address Book Add Mobile Alert
Yahoo! DomainKeys has confirmed that this message was sent by yahoogroups.com. Learn more
Date: Sat, 22 Apr 2006 01:43:00 -0000
Subject: [Hypogonadism] Issue facing Compounding Pharmacies
Firm Seeks Crackdown on Custom Made Drugs By ANDREW BRIDGES
Associated Press Writer
WASHINGTON Thousands of women who rely on custom-made hormone
drugs for relief from menopause symptoms have flooded the government
with letters opposing a drug company's effort to get health officials
to
crack down on pharmacies that sell them. The drug company Wyeth wants
the Food and Drug Administration to rein in the market for
bio-identical
hormone replacement therapy drugs. The hormones are custom mixed or
compounded by specialized pharmacies according to a doctor's
prescription.
[http://img.coxnewsweb.com/B/00/83/44/image_3344830.jpg]
<http://www.ajc.com/hp/content/shared-gen/ap/Health_Medical/Custom_Made_\
Drugs-image.html> (enlarge photo)
<http://www.ajc.com/hp/content/shared-gen/ap/Health_Medical/Custom_Made_\
Drugs-image.html> Donna Mabin, right, and cosmotologist Gladys Ayers,
left, look over a petition that they are having signed at the Park
Layne
hair salon, Monday, Feb. 27, 2006 in New Carlisle, Ohio. Thousands of
women who rely on tailor-prepared hormones for relief from the symptoms
of menopause have flooded the federal government with letters opposing
a
drug company effort to get health officials to act against the
pharmaces
that sell the prescription preparations. (AP Photo/David Kohl)
Compounding pharmacists can alter the dosages of a medicine, prepare it
in creams or liquids that are easier to take than pills or eliminate
preservatives or other secondary ingredients that might cause allergies
in a patient. Wyeth claims that some compounding pharmacies that
prepare
customized hormone preparations are duping women with products that
pose
a serious health risk. It wants federal regulators to weigh in with
seizures, injunctions and warning letters. "FDA cannot allow this
practice to continue," the Wyeth petition, signed by Washington
attorney
Andrew S. Krulwich, reads in part. FDA spokeswoman Susan Cruzan
declined
to comment, other than to say compounded hormones are not FDA-approved.
The agency recently told Wyeth it needs more than six months to review
and respond to both the petition, filed in October, and the more than
27,000 comments it has elicited. Most are either form letters or
messages submitted through the agency's Web site. "They can't take
these
away from us. Is there anything that can be done?" said Donna Mabin,
68,
a retired cashier from New Carlisle, Ohio, who was among those to
write.
"Those drug companies want to get the money out of natural hormones and
they don't care if we get sick or not." Many women turned to the
estrogen, progesterone and testosterone products sold by compounding
pharmacies after a 2002 study, part of the massive Women's Health
Initiative that tracked 161,000 women for 15 years, found replacement
hormones made by drug companies like Wyeth raised the risk of heart
attacks, breast cancer and strokes. Critics of the compounding
pharmacies want to dispel the notion that the hormone replacement
therapies such pharmacies make necessarily work better or are safer.
"They haven't been studied for safety or effectiveness and are not
produced in facilities that meet good manufacturing practices," said
Larry Sasich, a pharmacist with the Health Research Group of the
consumer watchdog Public Citizen. "We suspect a majority of patients
aren't aware of this." Medical researchers concluded in 2003 that
hormone replacement pills should be taken only as a brief treatment to
help women weather the worst symptoms of menopause. Those findings hit
Wyeth hard. Sales of the company's Prempro and Premphase, which combine
estrogen and progestin, and its Premarin, an estrogen-only pill, fell
to
$880 million in 2004 from $2.07 billion in 2001, the year before the
Women's Health Initiative released its hormone-replacement results.
Compounding pharmacists and their backers allege that Wyeth seeks to
stifle competition by calling in the FDA. "It seems to be an attempt to
use the FDA to inappropriately to eliminate competition," said L.D.
King, executive director of the International Academy of Compounding
Pharmacists, a Sugar Land, Texas, group. Wyeth counters it wants women
to realize the risks of what a spokeswoman for the Madison, N.J.-based
company characterized as a "growing, unlawful practice." "We filed our
petition so that we can ensure that women who received these
bio-identical hormones also receive truthful information about the
risks
of therapy," Wyeth spokeswoman Candace Steele said. Thousands of
American women use the compounded hormones to alleviate the hot
flashes,
flushes, sweats, sleeplessness and other hallmarks of menopause. The
hormones are derived from soy and yam but have an identical chemical
structure to the substances found in the body. The products sold by
Wyeth are based on the urine of pregnant mares. Women who use the
bio-identical hormones, along with their doctors and pharmacists, all
say the system is a throwback to when just about every medicine was
made
to fit both a doctor's order and a patient's need. "Every woman is
different. There is blood work done to ensure where their hormone level
is at, so based on those results and their symptoms, we will come up
with a formula. It's sort of old-fashioned," said Manhattan's Dr.
Jeffrey Morrison of the process he uses with patients like Lynn
Leibowitz. The doctor-pharmacist-patient "triad" involves constant
adjustments that just can't be made to the mass-produced drugs that
Leibowitz, a Manhattan psychologist and psychoanalyst, used to take,
said David Miller, the New Jersey compounding pharmacist she uses.
"We'll keep going month after month until we find the right combination
for the patients," Miller said of his work at Millers of Wyckoff, the
New Jersey pharmacy his grandfather started in 1929. As for Leibowitz,
she says the custom-compounded hormones have left her feeling better
and more in control since switching a year ago. "I love
knowing what my hormone levels are," said Leibowitz, who began taking
hormones eight years ago after she underwent a hysterectomy at 48. "I
feel much safer and it's more compatible with my body chemistry." That
sort of anecdotal evidence doesn't sway other doctors. In November, the
American College of Obstetricians and Gynecologists said there is no
scientific evidence supporting claims of increased efficacy or safety
for estrogen or progesterone regimens made by compounding pharmacies
for
women. The group said women should consider compounded hormones to have
the same or even additional safety issues as FDA-approved hormone
products. That same month, the FDA sent warning letters to 16 companies
marketing unapproved alternative hormone therapies. The FDA said the
companies were selling drugs without the agency's approval. The action
mirrored in part what Wyeth requested in its petition, but was not
linked to the filing of the document just weeks earlier, said Steele,
the company spokeswoman. And a 2004 review that appeared in Menopause,
the journal of the North American Menopause Society, found little to
recommend about compounded hormones: "In the absence of a sound
scientific basis, practitioners should not advocate the practice of
compounding (hormones) because it is not in the patient's best
interest,
it is potentially harmful and it lacks a scientific underpinning," the
review concluded.
[Non-text portions of this message have been removed]
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/hypogonadism2/
